By Raja Singh ChaudharyTMCnet Contributor
US Oncology Specialty, LP, the distribution facility of US Oncology, Inc. located in Fort Worth, Texas has announced that it has successfully passed the comprehensive criteria review and on-site inspection of the Verified-Accredited Wholesale Distributors (CM) program of the National Association of Boards of Pharmacy or “NABP.”
Power and Cooling Capacity Management for Data Centers Learn more, download free white paper.Deploying High-Density Zones in a Low-Density Data Center Learn more, download free white paper.Selecting an Industry-Standard Metric for Data Center Efficiency Learn more, download free white paper.Preventing Data Corruption in the Event of an Extended Power Outage Learn more, download free white paper.Guidance for calculation of efficiency (PUE) in real data centers Learn more, download free white paper.Implementing Energy Efficient Data Centers Learn more, download free white paper.Cooling Strategies for Ultra-High Density Racks and Blade Servers Learn more, download free white paper.
A provider of safe cancer therapy drugs to promote community oncology practices, US Oncology leverages US Oncology Specialty, its drug distribution center to protect the integrity of drugs administered to patients, and deploys advanced ePedigree technology for tracking drug therapies from manufacturer to patient.
Previously, US Oncology Specialty had been accredited by the NABP in the year 2006, and was the first oncology-specific wholesale distributor that had been accredited by the organization. Through its VAWD program, the NABP contributes in the efforts being made by state board of pharmacy for regulation of drug supply chain. The organization also helps in ensuring co-ordination between NABP and accredited wholesale distributors; so that the common public doesn’t receive counterfeit drugs and the integrity of the US medication distribution supply chain can be secured.
View the Original article